We are pleased to announce the winners of the Cancers 2021 Best Paper Award. All papers published in 2021 in Cancers (ISSN: 2072-6694) were considered for the award. After a thorough evaluation of the originality and significance of the papers, citations, and downloads, four winners were selected. The winners will receive CHF 500, a certificate, and a chance to publish a paper free of charge after peer review in Cancers before the end of 30 December 2023.
Winning Reviews:
“PD-L1, TMB, MSI, and Other Predictors of Response to Immune Checkpoint Inhibitors in Biliary Tract Cancer”
by Alessandro Rizzo, Angela Dalia Ricci and Giovanni Brandi
Cancers 2021, 13(3), 558; https://doi.org/10.3390/cancers13030558
Available online: https://www.mdpi.com/2072-6694/13/3/558
“STING Agonists as Cancer Therapeutics”
by Afsaneh Amouzegar, Manoj Chelvanambi, Jessica N. Filderman, Walter J. Storkus and Jason J. Luke
Cancers 2021, 13(11), 2695; https://doi.org/10.3390/cancers13112695
Available online: https://www.mdpi.com/2072-6694/13/11/2695
Winning Articles:
“LAG-3 Blockade with Relatlimab (BMS-986016) Restores Anti-Leukemic Responses in Chronic Lymphocytic Leukemia”
by Christian Sordo-Bahamonde, Seila Lorenzo-Herrero, Ana P. González-Rodríguez, Ángel R. Payer, Esther González-García, Alejandro López-Soto and Segundo Gonzalez
Cancers 2021, 13(9), 2112; https://doi.org/10.3390/cancers13092112
Available online: https://www.mdpi.com/2072-6694/13/9/2112
“The Role of the Immune Metabolic Prognostic Index in Patients with Non-Small Cell Lung Cancer (NSCLC) in Radiological Progression during Treatment with Nivolumab”
by Matteo Bauckneht, Carlo Genova, Giovanni Rossi, Erika Rijavec, Maria Giovanna Dal Bello, Giulia Ferrarazzo, Marco Tagliamento, Maria Isabella Donegani, Federica Biello, Silvia Chiola et al.
Cancers 2021, 13(13), 3117; https://doi.org/10.3390/cancers13133117
Available online: https://www.mdpi.com/2072-6694/13/13/3117
Please join us in congratulating the winners of the Cancers 2021 Best Paper Award. We would also like to take this opportunity to thank all of the authors who contributed to Cancers for their continued support.
